CAS: 394735-17-2 - Ethyl α-aminocyclobutanepropanoate
Formula:C9H17NO2
InChI:InChI=1S/C9H17NO2/c1-2-12-9(11)8(10)6-7-4-3-5-7/h7-8H,2-6,10H2,1H3
InChI key:InChIKey=LBMYKRXWOHTRIK-UHFFFAOYSA-N
SMILES:O=C(OCC)C(N)CC1CCC1
- Synonyms:
- Cyclobutanepropanoic Acid, Α-Amino-, Ethyl Ester
- Ethyl 2-amino-3-cyclobutylpropanoate
- Ethyl α-aminocyclobutanepropanoate
- Ethyl 3-cyclobutylalaninate
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Ethyl 2-amino-3-cyclobutylpropanoate REF: IN-DA00C6L6CAS: 394735-17-2 | - - - | To inquire | Tue 10 Dec 24 | |
Ethyl 2-amino-3-cyclobutylpropanoate REF: 54-OR930722CAS: 394735-17-2 | 95% | 253.00 €~527.00 € | Tue 17 Dec 24 | |
Ethyl 2-amino-3-cyclobutylpropanoate REF: 10-F235041CAS: 394735-17-2 | 95.0% | To inquire | Fri 20 Dec 24 | |
Ethyl 2-amino-3-cyclobutylpropanoate REF: 3D-UQA73517CAS: 394735-17-2 | Min. 95% | - - - | Discontinued product |
Ethyl 2-amino-3-cyclobutylpropanoate
CAS:394735-17-2
Formula:
C9H17NO2
Color and Shape:
Liquid
Molecular weight:
171.2368
Ref: IN-DA00C6L6
Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Ref: 54-OR930722
1g | 527.00 € | ||
250mg | 253.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
Ethyl 2-amino-3-cyclobutylpropanoate
CAS:394735-17-2
Purity:
95.0%
Color and Shape:
Liquid
Molecular weight:
171.24000549316406
Ref: 10-F235041
1g | To inquire | ||
5g | To inquire |
Estimated delivery in United States, on Friday 20 Dec 2024
Ethyl 2-amino-3-cyclobutylpropanoate
CAS:394735-17-2
Ethyl 2-amino-3-cyclobutylpropanoate is a synthetic compound that is an inhibitor of the enzyme connective tissue …
Formula:
C9H17NO2
Purity:
Min. 95%
Molecular weight:
171.24 g/mol
Ref: 3D-UQA73517
1g | Discontinued | Request information | |
5g | Discontinued | Request information | |
10g | Discontinued | Request information | |
10mg | Discontinued | Request information | |
100mg | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |